Masaryk University at ENA 2026

Nov 18–20, 2026 Barcelona, Spain ~1.5k attendees Website

Masaryk University brings 3 presentations to ENA 2026 in Barcelona. Its posters centre on p53-based cancer therapy, from how MDM2 inhibition reshapes the translatome and proteome to real-time in vivo monitoring of p53 activation. It also presents patient-specific 3D spheroid models showing how stiffness, stress and stroma shape pancreatic cancer progression.

Organization	ENA 2026 Attendance
Masaryk University Brno, Czech Republic
muni.cz Universities & institutes Public research university in Brno, Czech Republic, with faculties of medicine and science.	Poster Thu Nov 19 9:30–10am 1–3pm 4:30–5pm Part of Poster session: Molecular Targeted Agents Profound changes of the p53 network induction on the translatome and proteome levels determine cellular response to MDM2 inhibition Targeted agents Poster Fri Nov 20 10:45–11:15am 1:30–3pm Part of Poster session: Combination Therapies Optimizing p53/ISR-based cancer therapy through real-time in vivo monitoring of p53 activation Targeted agents Poster Fri Nov 20 10:45–11:15am 1:30–3pm Part of Poster session: Preclinical Models Stiffness, stress, and stroma: patient-specific 3D spheroid models reveal biomechanical and cellular determinants of pancreatic cancer progression Preclinical models

Organization

ENA 2026 Attendance

Masaryk University

Brno, Czech Republic

muni.cz

Universities & institutes

Public research university in Brno, Czech Republic, with faculties of medicine and science.

Poster

Thu Nov 19
9:30–10am
1–3pm
4:30–5pm

Part of Poster session: Molecular Targeted Agents

Profound changes of the p53 network induction on the translatome and proteome levels determine cellular response to MDM2 inhibition

Targeted agents